3.51
price up icon7.01%   0.23
 
loading

Precigen Inc Azioni (PGEN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Income/Loss From Continuing Operations Before Tax
449.36%
-146.34
-26.64 -54.15 -19.81 -23.97
Income Tax Expense/Benefit, Deferred
-
- - -0.089 0.012
Income Tax Expense/Benefit
100.00%
-
0.003 - -0.087 0.012
Income/Loss From Continuing Operations After Tax
449.30%
-146.34
-26.64 -54.15 -19.73 -23.98
Net Income/Loss
449.30%
-146.34
-26.64 -54.15 -19.73 -23.98
Preferred Stock Dividends And Other Adjustments
179.00
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.62%
307.17
296.43 293.88 8.4727 275.88
Diluted Average Shares
3.62%
307.17
296.43 293.88 8.4727 275.88
Basic Earnings Per Share
1,078%
-1.06
-0.09 -0.18 -0.06 -0.09
Diluted Earnings Per Share
1,078%
-1.06
-0.09 -0.18 -0.06 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
179.00
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):